MONROVIA, CA, November 07, 2008
/24-7PressRelease/ -- Michael Shih, Director of Business Development at Eisai Incorporated and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough will give the joint featured address entitled "CNS Deal Outlook: What We Can Learn From Recent Trends" at this year's CNS Diseases Partnering forum.
The presentation will take place in the Recent Deals in CNS session of the conference and will focus on the recent string of deals for novel approaches to treat unmet medical needs in the CNS category. Deals such as the GSK/Actelion (almorexant for insomnia), Astellas/CoMentis (CTS-21166, an oral beta-secretase inhibitor for Alzheimer's Disease), Pfizer/Medivation (dimebon for Alzheimer's Disease and Huntington's Disease), and Eli Lilly/BioMS (MBP8298 for Multiple Sclerosis) will be discussed along with what the immediate future of CNS partnering could look like.
The CNS Diseases Partnering & Deal-Making Summit takes a microscopic look at trends and developments in CNS diseases, from cutting-edge CNS disease research to early and late stage partnerships. Whether you are a business development professional or a CNS disease specialist, this conference will help you grasp a full scope of the market for new treatments and therapies for all types of CNS diseases. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=140.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- De Yang from the National Cancer Institute to Speak at the 7th Cytokines & Inflammation Conference
- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference
- Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio's 4th Imaging in Preclinical & Clinical Drug Development Conference
- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
Other Press Release Headlines:
